Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $10.16-$29.56 |
Market Cap | $1.2B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $54.5M |
Revenue Growth (YoY) | -12.4% |
Gross Profit (12 Mos) | -$167M |
Diluted EPS | -$2.88 |
News
See moreYahoo Finance • 9 days ago
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 19 days ago
Nurix Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Yahoo Finance • 26 days ago
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
